Matches in Wikidata for { <http://www.wikidata.org/entity/Q92946941> ?p ?o ?g. }
Showing items 1 to 64 of
64
with 100 items per page.
- Q92946941 description "article scientifique publié en 2019" @default.
- Q92946941 description "artículu científicu espublizáu en xunu de 2019" @default.
- Q92946941 description "scientific article published on 21 June 2019" @default.
- Q92946941 description "wetenschappelijk artikel" @default.
- Q92946941 description "наукова стаття, опублікована 21 червня 2019" @default.
- Q92946941 name "Erratum. A Randomized Controlled Trial Comparing Efficacy and Safety of Insulin Glargine 300 Units/mL Versus 100 Units/mL in Older People With Type 2 Diabetes: Results From the SENIOR Study. Diabetes Care 2018;41:1672-1680" @default.
- Q92946941 name "Erratum. A Randomized Controlled Trial Comparing Efficacy and Safety of Insulin Glargine 300 Units/mL Versus 100 Units/mL in Older People With Type 2 Diabetes: Results From the SENIOR Study. Diabetes Care 2018;41:1672-1680" @default.
- Q92946941 type Item @default.
- Q92946941 label "Erratum. A Randomized Controlled Trial Comparing Efficacy and Safety of Insulin Glargine 300 Units/mL Versus 100 Units/mL in Older People With Type 2 Diabetes: Results From the SENIOR Study. Diabetes Care 2018;41:1672-1680" @default.
- Q92946941 label "Erratum. A Randomized Controlled Trial Comparing Efficacy and Safety of Insulin Glargine 300 Units/mL Versus 100 Units/mL in Older People With Type 2 Diabetes: Results From the SENIOR Study. Diabetes Care 2018;41:1672-1680" @default.
- Q92946941 prefLabel "Erratum. A Randomized Controlled Trial Comparing Efficacy and Safety of Insulin Glargine 300 Units/mL Versus 100 Units/mL in Older People With Type 2 Diabetes: Results From the SENIOR Study. Diabetes Care 2018;41:1672-1680" @default.
- Q92946941 prefLabel "Erratum. A Randomized Controlled Trial Comparing Efficacy and Safety of Insulin Glargine 300 Units/mL Versus 100 Units/mL in Older People With Type 2 Diabetes: Results From the SENIOR Study. Diabetes Care 2018;41:1672-1680" @default.
- Q92946941 P1433 Q92946941-A0383376-A985-4DB6-9216-02C9A0DDC437 @default.
- Q92946941 P1476 Q92946941-83760391-0BF4-4271-ADF6-EA0DC49229DF @default.
- Q92946941 P2093 Q92946941-01562C2E-9126-4C13-ADE3-2CF7DF23DEF2 @default.
- Q92946941 P2093 Q92946941-095D5571-F456-4A3D-8897-707DC064D740 @default.
- Q92946941 P2093 Q92946941-2094FF12-987D-4ED1-B9BD-C16376C797F4 @default.
- Q92946941 P2093 Q92946941-3B6958AA-58B8-49B9-B59E-60DF80A2A2D4 @default.
- Q92946941 P2093 Q92946941-3E53C05E-2BDA-4FE4-8C82-EE1B1668B00C @default.
- Q92946941 P2093 Q92946941-4481B065-A9D9-4B17-B661-9B12789BA4F4 @default.
- Q92946941 P2093 Q92946941-5D535F7D-6F3E-446C-9188-754577EF86D5 @default.
- Q92946941 P2093 Q92946941-6FA8EA78-4D33-4DEE-A5C3-5EC17E48B311 @default.
- Q92946941 P2093 Q92946941-84E6AC1E-F4C7-4428-B7DF-7A89E39209A9 @default.
- Q92946941 P2093 Q92946941-8BDDECB2-A884-448B-B954-4CF53743EF5B @default.
- Q92946941 P2093 Q92946941-B5A1435A-DCE7-43C8-B6D1-78B19DCC0DC0 @default.
- Q92946941 P2093 Q92946941-F753C8D9-F210-420F-8E4E-351964533781 @default.
- Q92946941 P304 Q92946941-4EA492A2-803F-436A-B2D7-5DCE1B89C73A @default.
- Q92946941 P31 Q92946941-58491947-6B56-4E50-AC48-9502795F513C @default.
- Q92946941 P31 Q92946941-CD716731-084C-4D32-B608-720921006339 @default.
- Q92946941 P356 Q92946941-3EA13FB6-C9F9-4507-9993-F8D2F1CECDE7 @default.
- Q92946941 P433 Q92946941-AAFF2A40-9289-4960-BC8D-B014147E6667 @default.
- Q92946941 P478 Q92946941-13B5B18D-EE5F-4F0F-B20D-ECB73DBD7953 @default.
- Q92946941 P577 Q92946941-EFB0C9F2-1706-4A75-A5CB-B23B475D8A97 @default.
- Q92946941 P698 Q92946941-02F61D94-702A-4994-BC47-1E66B1D4ED70 @default.
- Q92946941 P921 Q92946941-5B0B0F03-5DEB-4639-A9FD-570D738C48B5 @default.
- Q92946941 P921 Q92946941-5F24A333-7CF6-4B7C-8CF9-16551562C963 @default.
- Q92946941 P932 Q92946941-CABD53C9-EF60-4FEC-AAC0-A02E4DEC1829 @default.
- Q92946941 P356 DC19-ER08 @default.
- Q92946941 P698 31227584 @default.
- Q92946941 P1433 Q5270111 @default.
- Q92946941 P1476 "Erratum. A Randomized Controlled Trial Comparing Efficacy and Safety of Insulin Glargine 300 Units/mL Versus 100 Units/mL in Older People With Type 2 Diabetes: Results From the SENIOR Study. Diabetes Care 2018;41:1672-1680" @default.
- Q92946941 P2093 "Claire Brulle-Wohlhueter" @default.
- Q92946941 P2093 "Geremia B Bolli" @default.
- Q92946941 P2093 "Helen Baron" @default.
- Q92946941 P2093 "Hermes Florez" @default.
- Q92946941 P2093 "Isabel Muehlen-Bartmer" @default.
- Q92946941 P2093 "Medha Munshi" @default.
- Q92946941 P2093 "Melanie Espinasse" @default.
- Q92946941 P2093 "Monica Bertolini" @default.
- Q92946941 P2093 "Nianxian Zhang" @default.
- Q92946941 P2093 "Robert Ritzel" @default.
- Q92946941 P2093 "Ronan Roussel" @default.
- Q92946941 P2093 "Stewart B Harris" @default.
- Q92946941 P304 "1604" @default.
- Q92946941 P31 Q13442814 @default.
- Q92946941 P31 Q1348305 @default.
- Q92946941 P356 "10.2337/DC19-ER08" @default.
- Q92946941 P433 "8" @default.
- Q92946941 P478 "42" @default.
- Q92946941 P577 "2019-06-21T00:00:00Z" @default.
- Q92946941 P698 "31227584" @default.
- Q92946941 P921 Q3025883 @default.
- Q92946941 P921 Q417317 @default.
- Q92946941 P932 "6647046" @default.